The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
          View 
        
      Event
    
      2023 CPhI Worldwide
    
        Date:
        
            2023/10/24
                        to 2023/10/26
                      
        Location:
        Barcelona, Spain
      
          View 
        
      Event
    
      2023 CPhI North America
    
        Date:
        
            2023/04/25
                        to 2023/04/27
                      
        Location:
        Philadelphia, USA
      
          View 
        
      Event
    
      Webinar: ASDs by Spray Drying: Process Development & Scale-Up
    
        Date:
        
            2023/03/22
                      
        Location:
        online
      
          View 
        
      Event
    
      2022 CPhI Worldwide
    
        Date:
        
            2022/11/01
                        to 2022/11/03
                      
        Location:
        Frankfurt, Germany
      
          View 
        
      Event
    
      2021 CPhI Worldwide
    
        Date:
        
            2021/11/09
                        to 2021/11/11
                      
        Location:
        Milan, Italy
      
      View

News / Mar 10, 2021
It's B Corp MonthWe are proud to be a B Corporation.

      View

News / Apr 28, 2021
World Day for Safety and Health at WorkSafety First, Quality Always

      View

Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDCHovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.

      View

Press Clipping / Nov 12, 2018
How Hovione grew from a basement lab to a global pharmaceutical services companyC&EN, November 12, 2018

      View

Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEOHovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022

Browser not supported

Search

Types

Press Room

Categories

2023 CPhI Worldwide

2023 CPhI North America

Webinar: ASDs by Spray Drying: Process Development & Scale-Up

2022 CPhI Worldwide

2021 CPhI Worldwide

It's B Corp Month

World Day for Safety and Health at Work

Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

How Hovione grew from a basement lab to a global pharmaceutical services company

Jean-Luc Herbeaux to become Hovione CEO